ARC
BBP icon

Advisor Resource Council’s Virtus Biotech ETF BBP Stock Holding History

Advisor Resource Council’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$801K Buy
9,639
+630
+7% +$51.8K 0.26% 79
2025
Q4 		$746K Buy
+9,009
New +$684K 0.27% 84

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MSL
MILLINGTON SECURITIES, LLC Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return

Advisor Resource Council's BBP Position: Q1 2026 in Review

Advisor Resource Council increased its Virtus Biotech ETF (BBP) stake by 7% in Q1 2026, buying an estimated $51.8K and bringing the position to 9,639 shares worth $801K. The position accounts for 0.26% of the portfolio, ranked #79.

Advisor Resource Council first reported a position in BBP in Q4 2025 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold BBP as of Q1 2026.

  • Advisor Resource Council held 9,639 shares of Virtus Biotech ETF worth $801K as of Q1 2026.
  • Advisor Resource Council bought 630 Virtus Biotech ETF shares in Q1 2026, an estimated $51.8K.
  • Virtus Biotech ETF made up 0.26% of Advisor Resource Council's portfolio in Q1 2026, its #79 holding.
  • Advisor Resource Council first reported a position in Virtus Biotech ETF in Q4 2025 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2026.

Based on Advisor Resource Council's 13F filing for Q1 2026, filed 7 May 2026.